Saracen Fund Managers, the Edinburgh based asset manager focused on long-term investing, has reduced the annual management charge on its TB Saracen UK Alpha Fund from 1.00 per cent to 0.75 per cent, effective immediately.
In an environment where costs and charges are foremost, this move allows UK Alpha to be competitive with many other UK equity funds whilst offering a demonstrably better historic track record and very high active share.
TB Saracen UK Alpha Fund invests primarily in small and medium sized UK companies and focuses on long-term capital growth. Since its launch in 1999, the fund has developed a strong track record consistently outperforming the MSCI UK All Cap index. It has been ranked in the top quartile for performance over the last one, three and five years, and over the 19 years since its launch.
Managed by Scott McKenzie (pictured), a fund management professional of 25 years’ experience in UK equity funds, the fund’s top holdings are in pharmaceuticals company Shire and financial consultants Alpha Financial Markets Consulting. More recently the fund has benefitted from takeover activity in stocks such as GKN and Laird Group.
McKenzie says: ‘The fee reduction reflects our desire to grow the fund in a competitive market. The fund has a very high active share, at 95 per cent, which compares favourably with the many UK equity funds charging active fees for a closet tracking service. The fund has an excellent track record with strong potential for future growth and we are confident it will attract a wider audience.’
Investment professionals can access the TB Saracen UK Alpha Fund on a wide variety of UK fund platforms.